GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

GlaxoSmithKline Pharmaceuticals GLAXO.NS · INR

Health Care · NSE · 🇮🇳 India

Compare

2,710.00

+7.34%

Close of 9 Nov 2026, in INR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in INR, from our data supplier.

FY2026

Revenue

₹38.22bn

FY2017FY2026

Net income

₹10.36bn

FY2017FY2026

Free cash flow

₹9.67bn

FY2017FY2026

Shareholders' equity

₹22.67bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue₹38.22bn₹37.26bn₹34.42bn₹32.26bn₹32.64bn₹28.99bn₹31.99bn₹30.99bn₹28.06bn₹29.08bn
Research and development₹32.2m₹26.1m₹25.4m₹19.1m₹18.3m₹18.1m₹21.8m₹23.3m₹22.5m₹19.0m
Operating income₹14.09bn₹12.61bn₹8.38bn₹8.38bn₹6.99bn₹5.20bn₹4.79bn₹5.57bn₹4.76bn₹3.93bn
Net income₹10.36bn₹9.28bn₹5.90bn₹6.11bn₹16.95bn₹3.58bn₹932.0m₹4.45bn₹3.51bn₹3.37bn
Diluted earnings per share61.1554.7534.8336.06100.0021.155.5026.2920.7019.89

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets₹43.24bn₹41.08bn₹35.57bn₹33.27bn₹46.33bn₹31.13bn₹31.36bn₹39.11bn₹39.47bn₹30.04bn
Cash and short-term investments₹27.56bn₹24.98bn₹18.57bn₹16.54bn₹29.03bn₹11.63bn₹10.62bn₹11.48bn₹12.70bn₹9.08bn
Total liabilities₹20.56bn₹21.57bn₹17.79bn₹15.85bn₹19.70bn₹16.14bn₹13.15bn₹17.71bn₹18.90bn₹9.97bn
Debt₹332.7m₹99.5m₹186.7m₹155.4m₹200.8m₹346.3m₹418.4m₹5.8m₹9.9m₹15.9m
Shareholders' equity₹22.67bn₹19.51bn₹17.78bn₹17.41bn₹26.63bn₹14.78bn₹18.21bn₹21.40bn₹20.57bn₹20.07bn
Shares outstanding169m169m169m169m169m169m169m169m169m169m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations₹10.22bn₹12.90bn₹5.82bn₹4.84bn₹8.11bn₹5.78bn₹4.90bn₹3.99bn₹4.73bn₹2.36bn
Capital spending−₹552.8m−₹230.2m−₹312.2m−₹440.4m−₹346.4m−₹442.3m−₹1.56bn−₹2.91bn−₹4.03bn−₹3.04bn
Free cash flow₹9.67bn₹12.67bn₹5.51bn₹4.40bn₹7.76bn₹5.34bn₹3.35bn₹1.08bn₹694.1m−₹684.3m
Dividends paid−₹7.14bn−₹7.49bn−₹5.42bn−₹15.26bn−₹5.07bn−₹6.78bn−₹3.39bn−₹2.96bn−₹2.54bn−₹4.24bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₹9.38bn₹9.95bn₹10.41bn₹9.80bn₹8.05bn₹9.51bn₹9.49bn₹10.11bn
Operating income₹2.80bn₹3.38bn₹3.51bn₹3.18bn₹2.36bn₹3.19bn₹2.73bn₹3.05bn
Net income₹2.37bn₹2.78bn₹2.96bn₹2.57bn₹2.05bn₹2.63bn₹2.30bn₹2.52bn
Diluted earnings per share14.0016.4017.4515.2012.1015.5213.5714.91
Cash from operations———₹1.84bn————
Capital spending———−₹170.0m————
Free cash flow———₹1.67bn————
Total assets—₹43.24bn—₹36.65bn—₹41.08bn—₹37.46bn
Cash and short-term investments₹27.57bn₹27.56bn₹20.61bn₹20.61bn₹24.98bn₹24.98bn₹21.11bn₹21.11bn
Debt—₹160.0m—₹137.5m—₹74.6m—₹106.1m
Shareholders' equity₹22.67bn₹22.67bn₹17.08bn₹17.08bn₹19.51bn₹19.51bn₹16.73bn₹16.73bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue5.8%5.7%3.6%
Operating income18.9%22.1%11.8%
Net income19.3%23.7%10.7%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin35.4%30.6%27.3%22.6%
Net margin26.0%22.3%25.6%19.4%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings41.045.264.752.613.283.0295.161.373.262.6
Price to sales11.111.311.110.06.810.38.68.89.27.3

Dividends and splits

Per share, in the currency the company pays

Paid for 31 years. Last went ex-dividend on 29 May 2026.

FY2027FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Paid in the year57.0042.0044.0032.0030.0030.0020.0020.00
  • 2-for-1 split · 11 Sept 2018
  • 2-for-1 split · 4 Jan 1995

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.